Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis.

Fujita, Kohei; Terashima, Tsuyoshi; Mio, Tadashi

Fujita, Kohei; Terashima, Tsuyoshi; Mio, Tadashi.

Afiliação

Fujita K; Division of Respiratory Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan. Electronic address: kfujita-oka@umin.ac.jp.
Terashima T; Division of Clinical Pathology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Mio T; Division of Respiratory Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

J Thorac Oncol ; 11(12): 2238-2240, 2016 12.

Article em En | MEDLINE | ID: mdl-27423391

Assuntos

Anticorpos Monoclonais/uso terapêutico; Tuberculose Pulmonar/etiologia; Idoso; Anticorpos Monoclonais Humanizados; Humanos; Masculino; Resultado do Tratamento; Tuberculose Pulmonar/genética; Tuberculose Pulmonar/patologia

Palavras-chave

Immune checkpoint inhibitor; Immunotherapy; Nivolumab; Opportunistic infection; Tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Anticorpos Monoclonais Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google